Point72 Asia (Singapore) Pte. Ltd. Immuneering Corp Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $532 Billion
- Q3 2024
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Immuneering Corp stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 17,824 shares of IMRX stock, worth $32,083. This represents 0.01% of its overall portfolio holdings.
Number of Shares
17,824
Previous 34,609
48.5%
Holding current value
$32,083
Previous $44.3 Million
0.19%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding IMRX
# of Institutions
41Shares Held
4.64MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA1.07MShares$1.93 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD810KShares$1.46 Million0.0% of portfolio
-
Black Rock Inc. New York, NY533KShares$960,0550.0% of portfolio
-
Morgan Stanley New York, NY449KShares$808,7590.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny246KShares$443,2860.0% of portfolio
About Immuneering Corp
- Ticker IMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,392,300
- Market Cap $47.5M
- Description
- Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...